The idea came to Nadia Ladak during her undergraduate years, in the way many startup concepts do—born from personal frustration with a product millions use but few dare to redesign. What if tampons didn't have to hurt?
Four years later, her Toronto-based company Marlow had raised $1.9 million by October 2024 to prove that menstrual care, an industry dominated by household names and decades-old designs, might still have room for innovation. The pitch is deceptively simple: a system that pairs organic cotton tampons with a water-based lubricant, meant to address insertion discomfort and dryness that conventional products often ignore.
The funding round, disclosed on October 4, 2024, drew backing from Love x Money Ventures and Dream Ventures. For Marlow, it represents validation of a concept that could easily have been dismissed as niche—or worse, unnecessary. But Ladak and her three co-founders (Simone Godbout, Harit Sohal, and Kiara Botha) insist they're tapping into something real. They met as students at Western University's Ivey Business School in 2020, united by a shared conviction: that period pain isn't something people should simply endure.
A Dip, Not a Coating
Marlow's product isn't quite what it sounds like at first blush. This isn't a pre-lubricated tampon pulled from a wrapper ready to go. Instead, users dip the tampon applicator into a 40 mL bottle of water-based lubricant just before insertion—a step the company frames as both deliberate and medically considered.
The tampons and lubricant have been tested together for safety and biocompatibility, according to Marlow, though the specifics of those tests remain somewhat opaque. The company has referenced regulatory approval in investor communications, but independent verification of formal FDA clearance has proven elusive as of early 2026.
It's a detail that matters. In the femtech space, where trust hinges on transparency and medical credibility, regulatory ambiguity can be a liability.
Building Momentum—and a TikTok Presence
Whatever questions linger about regulatory status, Marlow has found an audience. As of October 2024, the brand was stocked in over 200 retail locations across Canada and the U.S., including Whole Foods, and sells directly to consumers through its website and Amazon storefronts on both sides of the border.
Perhaps more telling is its social media footprint. "The TMI Club," Marlow's content hub focused on menstrual health education, has reportedly amassed more than 100 million views on TikTok—a metric that suggests the company has tapped into the kind of community-building that younger consumers expect from purpose-driven brands.
Projections shared with investors in early 2025 pointed to $1.2 million in revenue for 2024, with claims of triple-digit month-over-month growth. Those figures, like much in the startup world, come with the usual caveats: unaudited, unverified, and subject to the vagaries of early-stage scaling.
Expanding Beyond Canada
The capital raised in 2024 is earmarked for U.S. market expansion, deeper investment in Amazon as a sales channel, and new product development. (As of February 2026, the company was reportedly pursuing an additional $1.5 million funding round.) The company hasn't detailed what those future products might look like, but the implication is clear: Marlow appears to view its lubricated tampon system as a beachhead, not the full story.
In March, the startup announced a partnership with Canada's JUNO Awards as the event's official period care sponsor—a branding play that aligns Marlow with cultural visibility, even if the commercial impact remains to be seen.
The Bigger Question
Marlow is operating in a global tampon market valued north of $6 billion, a space long dominated by legacy players with entrenched distribution and brand loyalty. Breaking through requires more than a clever product tweak; it demands sustained consumer education, retail relationships that hold, and the ability to weather the inevitable skepticism that greets any challenger in personal care.
Whether Marlow's founders can pull that off is still an open question. The startup has shown early traction in key retail channels and built a differentiated offering. But the path from "interesting idea" to "category disruptor" is littered with well-funded companies that couldn't make the leap.
For now, Ladak and her team are betting that enough people have experienced the problem they're solving—even if they've never thought to demand a solution. If they're right, a $1.9 million seed round may prove to be just the beginning.
